ENO1 and breast cancer: Specifically, the ERK1/2-WTAP-dependent m6A methylation modification enhances the stability of ENO1 and its glycolytic activity, thereby providing metabolic support for the proliferation and metastasis of breast cancer cells (Ou et al., 2021).